Cost-benefit Analysis

Feb 8, 2016

Top 400 Taxpayers See Tax Rates Rise, But There’s More to the Story

As Americans were gathering party supplies to greet the New Year, the Internal Revenue Service released their annual report of cumulative tax data reported on the 400 tax r...

read in full

Feb 4, 2016

Chlorine Bleach Plants Needlessly Endanger 63 Million Americans

Chlorine bleach plants across the U.S. put millions of Americans in danger of a chlorine gas release, a substance so toxic it has been used as a chemical weapon. Greenpeace’s new repo...

read in full

Jan 25, 2016

U.S. Industrial Facilities Reported Fewer Toxic Releases in 2014

The Toxics Release Inventory (TRI) data for 2014 is now available. The good news: total toxic releases by reporting facilities decreased by nearly six percent from 2013 levels. Howe...

read in full

Jan 22, 2016

Methane Causes Climate Change. Here's How the President Plans to Cut Emissions by 40-45 Percent.

UPDATE (Jan. 22, 2016): Today, the Bureau of Land Management (BLM) released its proposed rule to reduce methane emissions...

read in full

more news

OMB Watch Releases Report on Bush Changes to Regulatory Process

Mar 15, 2007 by Matthew Madia

Today, OMB Watch released a full report titled A Failure to Govern: Bush's Attack on the Regulatory Process (download it here). This report outlines President Bush's recent amendments to Executive Order 12866 — Regulatory Planning and Review. The report details the potential impacts the amendments will have on federal agencies and the American public, as well as what the changes mean to democracy at large. A Failure to Govern: Bush's Attack on the Regulatory Process

read in full

Latest Watcher

Mar 7, 2007 by Matthew Madia

Be sure to check out the latest issue of our biweekly newsletter, The Watcher. Regulatory policy articles this time: Bush Continues Anti-Regulatory Efforts with Industry Nominee to CPSC Scientific Consultant Sparks Controversy over Conflicts of Interest In Congress, No Shortage of Fuel Economy Proposals

read in full

Latest Developments on Bush Changes to the Regulatory Process

Mar 1, 2007 by Matthew Madia

OMB Watch has created a new web center to be the one-stop source for news and developments on President Bush's recent amendments to Executive Order 12866. The web center will be frequently updated with fresh insights, news from Capitol Hill, and links to media coverage.

read in full

Bush Executive Order Will Make It Harder to Protect the Public

Feb 28, 2007 by Matthew Madia

OMB Watch's Drs. Gary Bass and Rick Melberth have an op-ed posted on CommonDreams.org. The piece derides President Bush's recent changes to E.O. 12866: His actions ... set in motion changes that could further delay or hinder public health, safety, environmental, and civil rights protections. Read the whole thing here

read in full

Latest Watcher

Feb 22, 2007 by Matthew Madia

Be sure to check out the latest issue of our biweekly newsletter, The Watcher. Reg policy articles this time: Congress Holds Hearings on Bush's Changes to Regulatory Process FDA Drug Approval Process under Scrutiny

read in full

Congress Holds Hearings on Bush's Changes to Regulatory Process

Congress held back-to-back hearings Feb. 13 on President George W. Bush's Executive Order that amended the federal regulatory process. The first hearing primarily addressed the content of the amendments and the Good Guidance Practices Bulletin, both issued Jan. 18. The second hearing focused more on the legal and institutional challenges Bush's amendments raise.

read in full

Two House Committees Examine Bush Regulatory Amendments

Feb 14, 2007 by Matthew Madia

Yesterday, two House subcommittees held back-to-back oversight hearings investigating President Bush's recent amendments to Executive Order 12866 — Regulatory Planning and Review. The first hearing, held by the House Science and Technology Committee subcommittee on Investigations and Oversight, delved into the specific impacts of the amendments.

OMB Watch's own Rick Melberth framed the amendments as the next step in a disturbing trend where the White House has adopted tools to delay regulation.
Rep. Brian Baird (D-WA) wondered how the marketplace incentivized certain protections.
Witness and former OIRA administrator Sally Katzen criticized the administration for exerting influence over agency guidance documents.
And subcommittee Chair Brad Miller (D-NC) chastised the influence of the Presidential appointees who will serve as Regulatory Policy Officers:

If an RPO makes the wrong decision for the wrong reason, we're not going to know about it. Rep. James Sensenbrenner (R-WI), the ranking member on the subcommittee, exhibited a lack of understanding of the issue at large. He claimed the amendments do not require "additional hurdles to be overcome" and he muddled the separate issues of market failures and cost-benefit analyses. He left abruptly in the middle of the hearing. The second hearing, held by the House Judiciary Committee subcommittee on Commercial and Administrative Law, focused on action Congress could take. Committee Chair John Conyers (D-MI) and subcommittee Chair Linda Sanchez (D-CA) both asked witnesses what Congress could do. While Columbia University law professor Peter Strauss admitted Congress's options are limited, Curtis Copeland from the Congressional Research Service pointed out that Congress may declare that Executive Orders not hold any legal sway. Rep. William Delahunt (D-MA) is ready to "wage war" on the "institutional combat" against the legislative branch. Read more from The Pump Handle here.

read in full

House Oversight on Bush's E.O. Amendments

Feb 9, 2007 by Matthew Madia

On Feb. 13, the House will hold a joint subcommittee hearing titled, "Amending Executive Order 12866: Good Governance or Regulatory Usurpation?" The hearing will include testimony by former OIRA administrator Sally Katzen, Georgetown law professor David Vladeck, and OMB Watch's own Rick Melberth. On Jan. 18, President Bush issued a slew of amendments to Executive Order 12866 — Regulatory Planning and Review. The amendments vary in their specific impact, but share the goal of slowing the regulatory process. On Jan. 30, The New York Times published a front page story on the amendments, pushing the issue into the national spotlight. Now, the House Science and Technology Committee Subcommittee on Investigations and Oversight and the House Judiciary Committee Subcommittee on Commercial and Administrative Law (say that three times fast) will hold a joint hearing to investigate. It is heartening to see Congress exercise its oversight power. Bush's decision to amend the regulatory process undermines our nation's public health and safety protections. Furthermore, it shifts certain Congressional powers into the White House, and shows Mr. Bush's contempt for the people's branch of government. Let's hope the White House is paying attention this Tuesday.

read in full

Latest Watcher

Feb 7, 2007 by Matthew Madia

Be sure to check out the latest issue of our biweekly newsletter, The Watcher. Reg policy articles this time: Media, Congress Begin to Examine Bush's Executive Order on Regulatory Process Congress Steps Up Oversight of Executive Branch

read in full

Media, Congress Begin to Examine Bush's Executive Order on Regulatory Process

President George W. Bush's Executive Order amending the regulatory process in significant ways didn't immediately garner the attention one might have expected from the mainstream media and Congress. The order set in motion changes that could further delay or hinder public health, safety, environmental, and civil rights protections. It was issued by the White House, with a press release, Jan. 18, and only OMB Watch and Public Citizen rang the alarm bells, calling attention to changes that give OMB's Office of Information and Regulatory Affairs (OIRA) even broader powers over agency actions.

read in full